SBRT radiation trial for central lung tumors
Part of Cancer, Injuries & trauma, Lungs & breathing clinical trials.
This trial studies a focused, high-dose radiation treatment called SBRT for lung tumors that are hard to operate on, including very central tumors near major airways or organs. It may help people control tumor growth while limiting radiation exposure to nearby critical structures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18) with a lung cancer diagnosis confirmed by biopsy/cell testing, or a known cancer that is growing back locally.
- Your general health is good enough for treatment (ECOG 0–2), and you’re expected to live at least 6 months.
- Your tumors fit specific “central” size and location limits on CT scan (one tumor up to 5 cm, or multiple nearby tumors totaling up to 5 cm).
- You either cannot have surgery for medical reasons or you chose not to have surgery.
- Before starting, all cancer spots must be treated with a cutting-edge local treatment plan (for example, radiation or surgery), especially if only a few spots are growing.
- You must have no pregnancy, and you (if able to have children) must use reliable birth control; you also must be willing to sign consent and come for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial tests how a single, high-dose radiation treatment (called SBRT) affects quality of life and outcomes for people with certain lung tumors. It's for adults with early-stage non-small cell lung cancer or a lung tumor that has spread from another cancer, as long as the tumor is small and in the outer part of the lung.
This study tests whether a single, very high-dose focused radiation treatment can control early-stage lung cancer. It may help people who can’t or prefer not to have surgery, by delivering precise radiation to the tumor while aiming to spare nearby tissue.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.